Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

171.24 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
News headline image
Fresh Look At Long Bonds ↗
As long as the S&P 500 outperforms long bonds (TLT) risk is on. 
Via Talk Markets
Topics Bonds Stocks
News headline image
Healthcare Playbook Revisited - Growth Plus Value ↗
Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on. 
Via Talk Markets
News headline image
Time For Gilead Sciences-Heavy ETFs? ↗
Gilead Sciences has underperformed the broader market this year by a hefty margin. 
Via Talk Markets
News headline image
Technical Correction Or Return Of The Bear Market? ↗
The QQQ chart right now has a few key aspects. 
Via Talk Markets
News headline image
It’s Really All About the Retail Sector Now ↗
Should XRT break the July calendar range low, we will once again be talking about the 80-month moving average or the 6–7-year business cycle low. 
Via Talk Markets
News headline image
Three Lessons For Investing In Biotech Companies ↗
Many successful blockbusters started with a small trial. But you should temper your expectations until a larger, more rigorous trial is conducted. 
Via Talk Markets
News headline image
3 Top ETFs to Buy Right Now ↗
These three exchange-traded funds could be winning plays for patient investors. 
Via The Motley Fool
News headline image
The 3 Best Biotech Stocks to Buy Now: September 2023 ↗
With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize. 
Via InvestorPlace
News headline image
Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed ↗
 
Via Benzinga
Topics ETFs
News headline image
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio? ↗
It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. 
Via Talk Markets
Topics ETFs
News headline image
BRICS And The Recent Headline ↗
At a time when the world is experiencing de-globalization, an alliance of countries including Brazil, Russia, China, South Africa and possibly India is a potential threat to the west. 
Via Talk Markets
News headline image
The US Dollar And Long Bonds Doing The Dosey Doe ↗
With BRICS happening ahead of Jackson Hole, it would be good to look at the technical charts on both the dollar and the long bonds. 
Via Talk Markets
News headline image
5 Meme Stocks to Sell Immediately, According to AI ↗
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Biotechnology On Drugs ↗
​​​​​​​Biotechnology has traded basically sideways since the start of 2023. 
Via Talk Markets
News headline image
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner ↗
Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years. 
Via Talk Markets
News headline image
3 Strong Biotech Performers To Watch As Sector Nears Breakout
As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming. 
Via MarketBeat
Topics ETFs
News headline image
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 ↗
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors. 
Via InvestorPlace
News headline image
Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk's stock, Pushing Valuation Past Denmark's GDP ↗
 
Via Benzinga
News headline image
CPI-Market Impact Now And Later? ↗
A discussion about inflation, bonds, calendar ranges, and places to park your money 
Via Talk Markets
Topics Bonds Economy
News headline image
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss ↗
The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline. 
Via Benzinga
Topics ETFs Economy
News headline image
5 Magnificent ETFs to Buy Hand Over Fist for the Second Half of 2023 ↗
These exchange-traded funds (ETFs) offer low or ultralow net expense ratios and are perfectly positioned to help investors grow their wealth. 
Via The Motley Fool
News headline image
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers ↗
 
Via Benzinga
News headline image
The July 6-Month Calendar Range SPY QQQ IWM TLT ↗
Looking at the SPY chart, we have had 7 trading days above the range high. However, to date, SPY has not really taken off from that level and sits more in consolidation mode. 
Via Talk Markets
News headline image
Now That The July 6-Month Calendar Range Is Set ↗
As this week begins with a test of the July 6-month calendar range high, should that level break down, it could mean a substantially wide trading range in store for the small caps. 
Via Talk Markets
News headline image
On A Winning Streak! Many Market Signs Appear More Bullish ↗
This past week corporate earnings announcements picked up speed. You may recall that we mentioned the large money center Banks had announced the week before. If you did not read last week’s issue, you... 
Via Talk Markets
News headline image
Major Sector ETFs Re-Set In July-Blueprint ↗
Retail XRT is in a Distribution phase and has to clear the 200-WMA and calendar range high at 67.42. A move under 63.40 would be weak. 
Via Talk Markets
News headline image
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
News headline image
Biotech Blues: Stay Balanced Through July Earnings Season ↗
Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts. 
Via Talk Markets
News headline image
Moderna: Declining Performance And Relative Weakness
Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal. 
Via MarketBeat
Topics ETFs
News headline image
Biotech And Healthcare Stocks Lagging ↗
Healthcare is a laggard with XLV down YTD but UNH is still a core position. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.